Modulation of feline bladder and distal urethral responses to dorsal sacral root stimulation by intrathecal administration of a kappa1-opioid agonist

Urology

Volumn 49, Issue 5, 1997, Pages 802-807

  Abdelmagid, Mostafa E ^a   Gajewski, Jerzy B ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CONTRACTION STIMULATING AGENT; KAPPA OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ARTICLE; BLADDER CONTRACTION; CAT; CONTROLLED STUDY; DORSAL ROOT; ELECTROSTIMULATION THERAPY; INTRATHECAL DRUG ADMINISTRATION; MALE; NEUROGENIC BLADDER; NONHUMAN; PRIORITY JOURNAL; URETHRA;

ANIMALS; CATS; DECEREBRATE STATE; ELECTRIC STIMULATION; LUMBOSACRAL PLEXUS; MALE; URETHRA; URINARY BLADDER;

EID: 0030903495     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00086-1     Document Type: Article

References (39)

1. Bradley WE, Wittmers LE, Chou SN, and Frensh L: Use of a radio transmitter receiver unit for the treatment of neurogenic bladder: a preliminary report. J Neurosurg 19: 782-786, 1962.
2. Holmquist B: Electromicturition by pelvic nerve stimulation in dogs. Scand J Urol Nephrol Suppl 2: 2-27, 1968.
3. Jonas U, and Tanagho EA: Studies on the feasibility of urinary bladder evacuation by direct spinal cord stimulation. II. Poststimulus voiding: a way to overcome outflow resistance. Invest Urol 13: 151-153, 1975.
4. Schmidt RA, Bruschini H, and Tanagho EA: Urinary bladder and sphincter responses to stimulation of dorsal and ventral sacral roots. Invest Urol 16: 300-304, 1979.
5. Tanagho EA, Schmidt RA, and Orvis BR: Neural stimulation for control of voiding dysfunction: a preliminary re-port in 22 patients with serious neuropathic voiding disorders. J Urol 142: 340-345, 1989.
6. Booth AM, Hisamitsu T, Kawatani M, and DeGroat WC: Regulation of urinary bladder capacity by endogenous opioid peptides. J Urol 133: 339-342, 1985.
7. Thor KB, Hisamitsu T, Roppolo JR, Tuttle P, Nagel J, and DeGroat WC: Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat. J Pharmacol Exp Ther 248: 1018-1025, 1989.
8. 3 subtype. J Pharmacol Exp Ther 251: 461-476, 1989.
9. Takemori AE, Ho BY, Naeseth JS, and Portoghese PS: Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 246: 255-258, 1988.
10. Rudy DC, Downie JW, and McAndrew JD: α-Chloralose alters autonomic reflex function of the lower urinary tract. Am J Physiol 261: R1560-R1567, 1991.
11. Tang PC: Levels of brainstem and diencephalon controlling micturition reflex. J Neurophysiol 18: 583-595, 1955.
12. Kalia PK, Madan R, Saksena R, Barta RK, and Gode GR: Epidural pentazocaine for postoperative pain relief. Anesth Analg 62: 949-950, 1983.
13. Kumor KM, Haertzen CA, Johnson RE, Kocker T, and Jasinski D: Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. J Pharmacol Exp Ther 238: 960-968, 1986.
14. Pfeiffer A, Brantl V, Herz A, and Emrich HM: Psychotomimesis mediated by kappa opiate receptors. Science 233: 774-776, 1986.
15. Bradley WE: Regulation of the micturition reflex by negative feedback. J Urol 101: 400-402, 1969.
16. deGroat WC: Mechanisms underlying recurrent inhibition in the sacral parasympathetic outflow to the urinary bladder. J Physiol (Lond) 257: 503-513, 1976.
17. Kontani H: In vivo inhibitory effects of stimulation at the central end of the pelvic nerve severed from urinary bladder on urinary bladder contraction in rats. Jpn J Pharmacol 46: 411-413, 1988.
18. Gajewski JB: Bladder and urethral responses to sacral root stimulation combined with an intrathecal drug administration in normal and spinally transected cats. Neurourol Urodyn 12: 382-383, 1993.
19. El-Salmy S, Downie JW, and Awad SA: Effect of acute selective sacral rhizotomy in cats on bladder and urethral function and the response to bethanechol chloride. J Urol 134: 795-799, 1985.
20. Rampal G, and Mignard P: Behavior of the urethral striated sphincter and of the bladder in the chronic spinal cat. Implications at the central nervous system level. Pflugers Arch 353: 33-42, 1975.
21. Lord JAH, Waterfield AA, Hughes J, and Kosterlitz HW: Endogenous opioid peptides: multiple agonists and receptors. Nature 267: 495-499, 1977.
22. Schulz R, Fease E, Wuster M, and Herz A: Selective receptors for β-endorphin on the rat vas deferens. Life Sci 24: 843-849, 1979.
23. Gouarderes C, and Cros J: Opioid binding sites in different levels of rat spinal cord. Neuropeptides 5: 113-116, 1984.
24. Castanas E, Blanc D, Bourhim N, Cupo A, Cantau P, and Giraud P: Reassessment of opioid binding sites in the rat brain. Neuropeptides 7: 369-380, 1986.
25. Glazer EJ, and Basbaum AI: Leucine enkephalin: localization in and axoplasmic transport by sacral parasympathetic preganglionic neurons. Science 208: 1479-1481, 1980.
26. Erdman SL, Kawatani KB, Thor KB, Eskay R, and deGroat WC: Identification of neuropeptides in Onuf's nucleus in the cat (abstract 10). Soc Neurosci 10: 432, 1984.
27. Cruz L, and Basbaum AI: Multiple opioid peptides and the modulation of pain: immunohistochemical analysis of dynorphin and enkephalin in the trigeminal nucleus caudalis and spinal cord of the cat. J Comp Neurol 240: 331-348, 1985.
28. deGroat WC, Kawatani M, Hisamitsu AM, Lowe I, Morgan C, Roppolo J, Booth AM, Nadelhaft I, Kuo D, and Thor K: The role of neuropeptides in the sacral autonomic reflex pathways of the cat. J Auton Nerv Syst 7: 339-350, 1983.
29. Kawatani M, Lowe IP, Booth AM, Backers MG, Erdman SL, and deGroat WC: The presence of leucine-enkephalin in the sacral preganglionic pathway to the urinary bladder of the cat. Neurosci Lett 39: 143-145, 1989.
30. Dray A, and Metsch R: Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids. J Pharmacol Exp Ther 231: 254-260, 1984.
31. Dray A, and Metsch R: Opioid receptor subtypes involved in the central inhibition of urinary bladder motility. Eur J Pharmacol 104: 47-53, 1984.
32. Hisamitsu T, and deGroat WC: The inhibitory effect of opioid peptides and morphine applied intrathecally and in-tracerebroventricularly on the micturition reflex in cat. Brain Res 298: 51-65, 1984.
33. Rawal N, Mollefors K, Axelsson K, Lingardh G, and Widman BA: An experimental study of urodynamic effects of epidural morphine and of naloxone reversal. Anesth Analg 62: 641-647, 1983.
34. Sheldon RJ, Nunan L, and Porreca F: Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. J Pharmacol Exp Ther 243: 234-240, 1987.
35. Stevens CW, Lacey CB, Miller KE, Elde R, and Seybold VS: Biochemical characterization and regional quantification of μ,δ and κ opioid binding sites in rat spinal cord. Brain Res 550: 77-85, 1991.
36. Lahti RA, VonVoigtlander PF, and Barsuhn C: Properties of a selective kappa agonist, U-50,488H. Life Sci 31: 2257-2260, 1982.
37. 3H-bremazocine binding to rat lumbosacral spinal cord membranes. Br J Pharmacol 84: 52-57, 1985.
38. Morris BJ, and Herz A: Distinct distribution of opioid receptor types in rat lumbar spinal cord. Naunyn Schmiedebergs Arch Pharmacol 336: 240-243, 1987.
39. Attali B, Gouarderes C, Mazarguil H, Audigier Y, and Cros J: Evidence for multiple "kappa" binding sites by use of opioid peptides in the guinea pig lumbosacral spinal cord. Neuropeptides 3: 53-64, 1982.